Skip to main content
. 2015 Jul-Sep;59(3):154–158.

Table 3.

AVGF therapy in cases included in the research

Eye with NVG
OD OS Total
Th: with AVGF N % N % N %
Avastin ® (Bevacizumab) 33 67.3 36 72.0 69 69.7
Macugen ® (Pegaptanib sodium) 5 10.2 4 8.0 9 9.1
Lucentis ® (Ranibizumab) 8 16.3 8 16.0 16 16.2
5 – FU ® (5-fluorouracil) 3 6.1 2 4.0 5 5.1
Total 49 100.0 50 100.0 99 100.0